PAPER Stoppe G, Staedt J

[Psychopharmacotherapy of behavioral disorders in patients with dementia].

Z Gerontol Geriatr. 1999 Jun;32(3):153-8. PubMed.

PAPER Schönknecht P, Pantel J, Schröder J

[Quantitative magnetic resonance tomography in diagnosis of Alzheimer dementia].

Z Gerontol Geriatr. 2001 Apr;34(2):101-7. PubMed.

PAPER Arlt S, Kontush A, Müller-Thomsen T, Beisiegel U

[Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease].

Z Gerontol Geriatr. 2001 Dec;34(6):461-5. PubMed.

PAPER Gasic-Milenkovic J, Loske C, Deuther-Conrad W, Münch G

Protein "AGEing"--cytotoxicity of a glycated protein increases with its degree of AGE-modification.

Z Gerontol Geriatr. 2001 Dec;34(6):457-60. PubMed.

PAPER Olde Rikkert MG, Rigaud AS

Melatonin in elderly patients with insomnia. A systematic review.

Z Gerontol Geriatr. 2001 Dec;34(6):491-7. PubMed.

PAPER van Iersel MB, Hoefsloot W, Munneke M, Bloem BR, Olde Rikkert MG

Systematic review of quantitative clinical gait analysis in patients with dementia.

Z Gerontol Geriatr. 2004 Feb;37(1):27-32. PubMed.

PAPER van den Bussche H

[Questions and theses of pharmacological therapeutic options of Alzheimer's dementia with acetylcholinesterase inhibitors].

Z Gerontol Geriatr. 2005 Sep;38 Suppl 1:I18-20. PubMed.

PAPER Illes F, Bernhardt T, Prell K, Rietz C, Rudinger G, Frölich L, Maier W, Rietschel M

[Attitudes towards predictive genetic testing for Alzheimer's disease].

Z Gerontol Geriatr. 2006 Jun;39(3):233-9. PubMed.

PAPER Bornhöft G, Maxion-Bergemann S, Matthiessen PF

[External validity of clinical trials for treatment of dementia with ginkgo biloba extracts].

Z Gerontol Geriatr. 2008 Aug;41(4):298-312. PubMed.

PAPER Schröder J, Kaiser E, Schönknecht P, Hunt A, Thomann PA, Pantel J

[CSF levels of total tau protein in patients with mild cognitive impairment and Alzheimer's disease].

Z Gerontol Geriatr. 2008 Dec;41(6):497-501. PubMed.

PAPER Bauer C, Rietsch C, Gröger I, Gaßmann KG

[Mobility and safety for elderly (MoSi), a new intervention to improve mobility and gait in elderly people].

Z Gerontol Geriatr. 2009 Oct;42(5):360-4. PubMed.

PAPER Luck T, Riedel-Heller SG, Wiese B, Stein J, Weyerer S, Werle J, Kaduszkiewicz H, Wagner M, Mösch E, Zimmermann T, Maier W, Bickel H, van den Bussche H, Jessen F, Fuchs A, Pentzek M,

[CERAD-NP battery: Age-, gender- and education-specific reference values for selected subtests. Results of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)].

Z Gerontol Geriatr. 2009 Oct;42(5):372-84. PubMed.

PAPER Nehen HG, Honneth J, Haseke J, Fahnenstich H

[Significance of CSF levels of tau protein and beta42-amyloid for diagnosis and differential diagnosis of dementia diseases in a specialized geriatric hospital].

Z Gerontol Geriatr. 2009 Oct;42(5):391-3. PubMed.

PAPER Denkinger MD, Nikolaus T, Denkinger C, Lukas A

Physical activity for the prevention of cognitive decline: current evidence from observational and controlled studies.

Z Gerontol Geriatr. 2012 Jan;45(1):11-6. PubMed.

PAPER Jamour M, Becker C, Synofzik M, Maetzler W

[Gait changes as an early indicator of dementia].

Z Gerontol Geriatr. 2012 Jan;45(1):40-4. PubMed.